Assented Bills of previous Parliaments

Search all bills

Keyword(s)
Status
Current Bills
Previous Bills
Type

TOTAL RESULTS: 4139

  • Date
    24 May 2007 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health and Ageing 
    Summary
    Amends the
    National Health Act 1953
    to change the pricing arrangements for drugs after they are listed on the Pharmaceutical Benefits Scheme, by classifying drugs into formularies and specifying new pricing rules and supply requirements for drugs that have multiple brands and for single brand combination items. Also includes provisions for drugs requiring special pricing arrangements and makes minor, technical and consequential amendments. 

    Bill | Explanatory Memorandum

  • Date
    29 May 2008 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health and Ageing 
    Summary
    Amends the
    National Health Act 1953
    to: expand the criteria for determining that brands of pharmaceutical items are co-marketed; provide access to the Pharmaceutical Benefits Scheme (PBS) for government officers (and accompanying spouses and dependants) working overseas; enable married or de facto couples living apart permanently due to illness or infirmity to use the PBS safety net jointly; and make minor technical amendments. 

    Bill | Explanatory Memorandum

  • Date
    29 Sep 2010 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health and Ageing 
    Summary
    Amends the:
    National Health Act 1953
    in relation to: pricing arrangements for certain medicines listed on the Pharmaceutical Benefits Scheme; price disclosure arrangements; and the collection of under co-payment data; and
    Health Insurance Act 1973
    and
    Medicare Australia Act 1973
    to make consequential amendments. 

    Bill | Explanatory Memorandum

  • Date
    23 May 2012 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health and Ageing 
    Summary
    Amends the
    National Health Act 1953
    to: provide for prices for medicines supplied under the Pharmaceutical Benefits Scheme (PBS) to be expressed uniformly across different programs based on one ex-manufacturer price for all brands of a pharmaceutical item; provide for this uniform price to be used to set prices for different quantities of a pharmaceutical item and to calculate price changes, patient charges and price disclosure reductions; and make technical amendments in relation to listing PBS medicines for supply only through PBS prescriber bags. 

    Bill | Explanatory Memorandum

  • Date
    15 Aug 2007 
    Chamber
    Senate 
    Status
    Act 
    Portfolio
    Health and Ageing 
    Summary
    Amends the
    Health Insurance Act 1973
    and
    National Health Act 1953
    to allow authorised optometrists to prescribe certain ophthalmic (eye) medicines for supply under the Pharmaceutical Benefits Scheme. Also amends the
    National Health Act 1953
    to clarify the supply of pharmaceutical benefits ‘at or from’ approved premises. 

    Bill | Explanatory Memorandum

  • Date
    27 May 2015 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to implement the Pharmaceutical Benefits Scheme (PBS) Access and Sustainability package by: applying a one-off five per cent statutory price reduction for single brand medicines; changing price disclosure arrangements for multiple-brand medicines; applying flow-on price disclosure reductions from component drugs to multiple-brand combination medicines; changing membership arrangements for the Pharmaceutical Benefits Advisory Committee; enabling approved pharmacists to discount patient co-payments by a maximum of $1 for each PBS supply on a prescription; extending safety net early supply rules; and extending the pharmacy location rules and the role of the Australian Community Pharmacy Authority to 30 June 2020. Also makes technical amendments. 

    Bill | Explanatory Memorandum

  • Date
    24 Nov 2016 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: enable the minister, the secretary or the Chief Executive Medicare to arrange for the use of computer programs to make decisions and determinations, exercise powers or comply with obligations and do anything else related to those actions; enable approved pharmacists whose premises have been affected by disaster or exceptional circumstances to supply pharmaceutical benefits at alternative premises in the same locality for a limited period and be paid for claims at the full rate; and ensure that entitlements for concessional beneficiaries and their dependants will apply for pharmaceutical benefits until midnight on the day of a person’s death. 

    Bill | Explanatory Memorandum

  • Date
    04 Jul 2019 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: introduce a fee for applications by pharmacists for approval to supply Pharmaceutical Benefits Scheme medicines at particular premises; and enable pharmaceutical benefits to continue temporarily to be supplied following bankruptcy or where there is an external administrator in relation to the pharmacy. 

    Bill | Explanatory Memorandum

  • Date
    18 Oct 2017 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health 
    Summary
    Amends the
    National Health Act 1953
    to: increase the current statutory price reduction that applies when the first new brand of an existing pharmaceutical item is listed on the Pharmaceutical Benefits Scheme (PBS); extend and introduce statutory price reductions applying on certain anniversaries of an F1 formulary drug being listed on the PBS; introduce ministerial discretion in relation to the application of statutory price reductions in certain circumstances; make minor amendments to price disclosure arrangements; provide new circumstances whereby a new presentation of a brand of pharmaceutical item may be listed without being subject to a new brand statutory price reduction; continue the operation of the Australian Community Pharmacy Authority and the pharmacy location rules beyond 30 June 2020; and make technical amendments. 

    Bill | Explanatory Memorandum

  • Date
    13 Nov 2002 
    Chamber
    House of Representatives 
    Status
    Act 
    Portfolio
    Health and Ageing 
    Summary
    Amends the
    National Health Act 1953
    to increase Pharmaceutical Benefits Scheme patient co-payments and safety net thresholds. 

    Bill | Explanatory Memorandum